Shareholders of SynAct Pharma proposes Uli Hacksell as new
AKTIELIVET on Twitter: "SYNACT Hacksells meriter och
公司总裁：Uli Hacksell, 注册地址：Delaware, 员工 Nov 29, 2016 Uli Hacksell, President and. Chief Executive Officer of Cerecor. "We intend to more fully assess the results from this trial as we continue to receive 本社所在地, 400 E. Pratt Street Suite 606 Baltimore MD 21202 USA. 代表者氏名, Uli Hacksell ウリ・ハッスル. 代表者役職名, Chairman of the Board 取締役会会長.
Dr. Hacksell served as Chief Executive Officer and as a director of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors. He initially joined ACADIA as Executive Vice President of Drug Discovery. Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer Mr. Harrell has a great breadth of biopharmaceutical industry experience. Jamie joined Cerecor in May of 2018 as the Executive Vice President of Marketing and Communications and was promoted to Chief Commercial Officer in November of 2019 with the divestiture of Pediatric portfolio of products.
Shareholders of SynAct Pharma proposes Uli Hacksell as new
Har tidigare bland annat varit VD för ACADIA och haft Uli Hacksell är född 1950. Han är styrelseordförande i Cerecor Inc., samt styrelseledamot i InDex Pharmaceuticals AB, Beactica AB och Uppsala universitet. https://biography.omicsonline.org/sweden/uppsala-university/ulla-lindqvist-1472796 https://biography.omicsonline.org/sweden/cerecor/uli-hacksell-1472790 SYNACT Hacksells meriter och erfarenheter kommer bli guldvärda för bolaget.
InDex Pharmaceuticals - Redeye
Uli Hacksell is listed as an insider in the following companies: CERC / Cerecor Inc. ACAD / ACADIA Pharmaceuticals, Inc. Insiders are officers, directors, or significant investors in a company. It is illegal for insiders to make trades in their companies based on specific, non-public information.
Exhibit 10.11 . CERECOR INC. May 20, 2015 . Uli Hacksell . Re: Position as the Chairman of the Board of Directors of Cerecor Inc. Dear Uli: I am very pleased to offer you the position as a member of the Board of Directors (the “Board”) of Cerecor Inc. (the “Company”). Dr. Hacksell served as Chief Executive Officer and as a director of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors. He initially joined ACADIA as Executive Vice President of Drug Discovery. Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer
Mr. Harrell has a great breadth of biopharmaceutical industry experience.
Vad är lättaste sättet att ta livet av sig
Han är styrelseordförande i Cerecor Inc., samt styrelseledamot i InDex Pharmaceuticals AB, Beactica AB och Uppsala universitet.
Mariam Morris. 1st. Uli Hacksell.
Vi 200b
apm configuration management
norwegian names
muumin
johan eriksson öppna myndigheten
Aktieägare i SynAct Pharma föreslår Uli Hacksell som - Cision
Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer Mr. Harrell has a great breadth of biopharmaceutical industry experience. Jamie joined Cerecor in May of 2018 as the Executive Vice President of Marketing and Communications and was promoted to Chief Commercial Officer in November of 2019 with the divestiture of Pediatric portfolio of products.
Baseexception filter
vardcentral st lars
AKTIELIVET on Twitter: "SYNACT Hacksells meriter och
2017-08-16 * Cerecor Inc announces retirement of Dr. Uli Hacksell as president and chief executive officer * Cerecor Inc says John Kaiser, chief business officer of Cerecor, has been appointed interim chief Cerecor Inc. Announces Retirement of Dr. Uli Hacksell as President and Chief Executive Officer. BALITIMORE, MD--(Marketwired - August 14, 2017) - Cerecor Inc. (NASDAQ: CERC), a clinical-stage biopharmaceutical company developing innovative drug candidates for patients with neurologic and neuropsychiatric disorders, today announced that Dr. Uli Hacksell has retired as Cerecor's President … August 15, 2017 By Alex Keown, BioSpace.com Breaking News Staff BALTIMORE, MD – One day after the abrupt resignation of Chief Executive Officer Uli Hacksell, Cerecor Inc. announced it was divesting a drug therapy for major depressive order to Janssen Pharmaceuticals for up to $45 million. Cerecor said it is selling the rights to its oral kappa opioid receptor antagonist CERC-501. Uli Hacksell.
https://biography.omicsonline.org/sweden/university-of
Född: 1950 Titel: Koncernchef och VD Utbildning: Apotekare och Farm dr. Bakgrund: Över 25 år i ledande befattningar på stora läkemedels- och bioteknikföretag och över 10 års erfarenhet som vd för publika bolag. Uli Hacksell Net Worth The estimated Net Worth of Uli Hacksell is at least $65.8 Mille dollars as of 10 December 2016.
Biography. Dr. Hacksell serves as Chairman of the Board of Directors, a position he has held since May of 2015. Prior to Cerecor, Dr. Hacksell served as Chief Executive Officer of ACADIA Pharmaceuticals, Inc., or ACADIA, from September 2000 to March 2015 and was a member of its Board of Directors.